The synthesis of shaped metal nanoparticles to meet the precise needs of emerging applications requires intentional synthetic design directed by fundamental chemical principles. We report an integrated electrochemistry approach to nanoparticle synthetic design that couples current-driven growth of metal nanoparticles on an electrode surfacein close analogy to standard colloidal synthesiswith electrochemical measurements of both electrochemical and colloidal nanoparticle growth. A simple chronopotentiometry method was used to translate an existing colloidal synthesis for corrugated palladium (Pd) nanoparticles to electrochemical growth on a glassy carbon electrode, with minimal modification to the growth solution. The electrochemical synthesis method was then utilized to produce large Pd icosahedra, a shape whose synthesis is challenging in a colloidal growth environment. This electrochemical synthesis for Pd icosahedra was used to develop a corresponding colloidal growth solution by tailoring a weak reducing agent to the measured potential profile of the electrochemical synthesis. Finally, measurements of colloidal syntheses were employed as guides for the directed design of electrochemical syntheses for Pd cubes and octahedra. Together, this work provides a cyclical approach to shaped nanoparticle design that allows for the optimization of nanoparticles grown via a colloidal approach with a chemical reducing agent or synthesized with an applied current on an electrode surface as well as subsequent bidirectional translation between the two methods. The enhanced chemical flexibility and direct tunability of this electrochemical method relative to combinatorial design of colloidal syntheses have the potential to accelerate the synthetic design process for noble metal nanoparticles with targeted morphologies.

Recent catalytic work has highlighted the importance of grain boundaries in the design of highly active catalyst materials due to the high energy of atoms at strained defect sites. In addition, undercoordinated atoms have long been known to contribute to the catalytic performance of metal nanoparticles. In this work, we describe a method for deliberately increasing the coverage of defect boundaries and undercoordinated atoms at the surfaces of well-defined, symmetric palladium nanoparticles. Careful control of the competitive interactions of chloride and bromide ions with the surface of twinned palladium nanoparticles is used to drive the growth of fin-like structures to extend the area of exposed twin boundaries while also inducing corrugation at the particle surface to add further undercoordinated sites. Mechanistic studies show surface passivation by bromide and etching by chloride in the presence of a low concentration of surfactant to be the key factors that tailor the surface of these nanoparticles, while the internal defect structure is controlled by reaction kinetics. Importantly, these basic principles of competition between surface passivation and etching as well as kinetic control of twin structure are not unique to palladium, and thus this method has the potential to be extended to the enhancement of surface defect density for nanoparticles composed of other catalytically relevant metals.

Halide ions catalytically enhance metal ion reduction rate, providing a versatile design tool for controlling metal nanoparticle growth.

A highly sensitive bioanalytical method based on a simple liquid/liquid extraction and hydrophilic interaction liquid chromatography with tandem mass spectrometry (HILIC/MS/MS) analysis has been developed, validated and transferred for the determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), a tobacco-specific nitrosamine metabolite. Deuterated NNAL (NNAL-d(4)) was synthesized and used as the internal standard. This method can be used for the analysis of free and total NNAL (free NNAL plus NNAL-gluc) in K(3)-EDTA human plasma. Free NNAL and NNAL-d(4) are extracted from human plasma by liquid/liquid extraction. To analyze for total NNAL and the internal standard, a separate aliquot of the K(3)-EDTA human plasma is treated with beta-glucuronidase to deconjugate the NNAL-gluc; the total NNAL and internal standard are then extracted using liquid/liquid extraction. After drying down under nitrogen, the residue is reconstituted with acetonitrile and analyzed using positive ion electrospray and HILIC/MS/MS at a flow rate of 1.0 mL/min. The chromatographic run time is 1.0 min per injection, with retention time for both NNAL and NNAL-d(4) of 0.75 min with a capacity factor (k') of 2. The standard curve range for this assay is from 5.00-1000 pg/mL for both free and total NNAL, using a total plasma sample volume of 1.0 mL. The interday precision and accuracy of the quality control (QC) samples demonstrated <7.6% relative standard deviation (RSD) and <3.3% relative error (RE) for free NNAL. For total NNAL, the interday precision and accuracy of the QC samples demonstrated <11.7% RSD and <2.8% RE. Optimization of enzyme hydrolysis of NNAL-gluc is discussed in detail. The overall recoveries for free and total NNAL and IS were 68.2 and 71.5% (free) and 70.7 and 65.5% (total). No adverse matrix effects were noticed for this assay.